RBKBHIGH SIGNALREGULATORY10-K

Rhinebeck Bancorp announced a second-step conversion from mutual holding company to fully public structure while delivering a dramatic turnaround from an $8.6M loss to $10.0M profit despite interest expenses surging 236%.

The second-step conversion represents a fundamental corporate restructuring that will significantly change the ownership structure and capital base, requiring multiple regulatory approvals and shareholder votes. This conversion typically unlocks shareholder value but also subjects the company to full public market dynamics and eliminates the mutual structure's inherent conservatism.

Comparing 2026-03-13 vs 2025-03-25View on EDGAR →
FINANCIAL ANALYSIS

The company achieved a remarkable financial turnaround with net income swinging from a -$8.6M loss to $10.0M profit (+216.5%), despite interest expenses surging 236% to $22.7M reflecting the challenging rate environment. The provision for credit losses improved dramatically from -$3.7M to $1.4M, operating cash flow grew 38.6% to $11.7M, and stockholders' equity increased 12.3% to $136.9M, indicating strong underlying business performance that supports the timing of their conversion to public structure.

FINANCIAL STATEMENT CHANGES
Interest Expense
P&L
+235.9%
$6.8M$22.7M

Interest expense surged 235.9% — significant debt increase or rising rates materially impacting earnings.

Net Income
P&L
+216.5%
-$8.6M$10.0M

Net income grew 216.5% — bottom-line growth signals improving overall business health.

Provision for Credit Losses
P&L
+138.6%
-$3.7M$1.4M

Credit loss provisions surged 138.6% — management flagging significant deterioration in loan quality ahead.

Operating Cash Flow
Cash Flow
+38.6%
$8.5M$11.7M

Operating cash flow surged 38.6% — exceptional cash generation, highest quality earnings signal.

Stockholders Equity
Balance Sheet
+12.3%
$121.8M$136.9M

Equity base grew 12.3% — retained earnings accumulation or equity issuance strengthening the balance sheet.

LANGUAGE CHANGES
NEW — 2026-03-13
PRIOR — 2025-03-25
ADDED
Except as required by applicable law or regulation, we do not undertake, and we specifically disclaim any obligation, to release publicly the results of any revisions that may be made to any forward-looking statements to reflect events or circumstances after the date of the statements or to reflect the occurrence of anticipated or unanticipated events.
At December 31, 2025, the Company had consolidated total assets of $1.30 billion, total deposits of $1.10 billion and stockholders equity of $136.9 million.
On February 10, 2026, Rhinebeck Bancorp, MHC adopted a Plan of Conversion and Reorganization, pursuant to which Rhinebeck Bancorp, MHC is proposing to convert from the mutual holding company structure to the fully public stock holding company structure, in a transaction commonly referred to as a second-step conversion.
The second-step conversion requires the approval of the NYSDFS and the Federal Reserve Board, as well as the depositors of Rhinebeck Bank and the stockholders of the Company.
We provide a full range of banking and financial services to consumer and commercial customers through our corporate office and 12 branches located in Dutchess, Orange and Ulster Counties.
+7 more — sign up free →
REMOVED
At December 31, 2024, the Company had consolidated total assets of $1.26 billion, total deposits of $1.02 billion and stockholders equity of $121.8 million.
The Bank provides a full range of banking and financial services to consumer and commercial customers through its 13 branches and one representative office located in Dutchess, Ulster and Orange counties.
We also maintain a representative office in Albany County to originate indirect automobile and commercial loans.
The Bank is subject to regulation and examination by the NYSDFS and by the Federal Deposit Insurance Corporation (the FDIC ).
We also maintain a representative office in Albany County to originate indirect automobile and commercial loans.
+7 more — sign up free →
MORE REGULATORY SIGNALS
BCHTHIGHBCHT has added extensive PFAS chemical definitions to their 10-K while removing ...
2026-03-31
OMERHIGHOMER achieved FDA approval for YARTEMLEA in December 2025, transforming from a c...
2026-03-31
UNCYHIGHThe FDA issued a Complete Response Letter (CRL) in June 2025 rejecting UNCY's dr...
2026-03-30
NVNOHIGHNVNO received a not-approvable letter from the FDA for its lead product VenoValv...
2026-03-26
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →